Blood Transfusion - 1 2019 (January-February)
Original article
-
A model-based cost-effectiveness analysis of Patient Blood Management
-
Screening and identification of RhD antigen mimic epitopes from a phage display random peptide library for the serodiagnosis of haemolytic disease of the foetus and newborn
-
SMIM1 polymorphisms in a donor population from Southeast Brazil and their correlation with VEL expression
-
ABO blood groups and psychiatric disorders: a Croatian study
-
High resolution melting for F9 gene mutation analysis in patients with haemophilia B
Review
Letter to the Editor
-
On the cost-utility of methylene blue-photoinactivated plasma versus quarantine plasma in Spain
-
Cost of Pathogen Reduction for platelets: reply to Cicchetti et al. Blood Transfus 2018; 16: 483-9
-
Reply to "High-titre inhibitors in previously untreated patients with severe haemophilia A receiving recombinant or plasma-derived factor VIII: a budget-impact analysis" by Messori et al.
-
Further comments on "High-titre inhibitors in previously untreated patients with severe haemophilia A receiving recombinant or plasma-derived factor VIII: a budget-impact analysis"